Rafferty Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$20.68 - $39.85 $847,693 - $1.63 Million	40,991 Added 80.01%	92,224 $1.97 Million
Q1 2023 May 11, 2023	SELL	$38.82 - $54.59 $1.25 Million - $1.76 Million	-32,181 Reduced 38.58%	51,233 $2.07 Million
Q4 2022 Feb 13, 2023	BUY	$40.77 - $53.73 $802,842 - $1.06 Million	19,692 Added 30.9%	83,414 $3.88 Million
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $411,720 - $607,648	8,526 Added 15.45%	63,722 $3.31 Million
Q2 2022 Aug 12, 2022	SELL	$38.13 - $76.93 $91,817 - $185,247	-2,408 Reduced 4.18%	55,196 $2.61 Million
Q1 2022 May 13, 2022	BUY	$56.06 - $74.11 $538,568 - $711,974	9,607 Added 20.02%	57,604 $4.1 Million
Q4 2021 Feb 10, 2022	BUY	$60.19 - $97.37 $1.35 Million - $2.19 Million	22,444 Added 87.83%	47,997 $3.59 Million
Q3 2021 Nov 10, 2021	BUY	$41.02 - $58.65 $42,742 - $61,113	1,042 Added 4.25%	25,553 $1.45 Million
Q2 2021 Aug 10, 2021	SELL	$43.76 - $53.11 $421,802 - $511,927	-9,639 Reduced 28.23%	24,511 $1.08 Million
Q1 2021 May 10, 2021	BUY	$41.69 - $54.95 $1.08 Million - $1.42 Million	25,921 Added 315.0%	34,150 $1.68 Million
Q4 2020 Feb 10, 2021	SELL	$41.16 - $47.47 $270,791 - $312,305	-6,579 Reduced 44.43%	8,229 $346,000
Q3 2020 Nov 13, 2020	BUY	$43.36 - $53.53 $249,710 - $308,279	5,759 Added 63.64%	14,808 $678,000
Q2 2020 Aug 07, 2020	BUY	$46.37 - $57.58 $419,602 - $521,041	9,049 New	9,049 $454,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $742,863 - $1.15 Million	-18,470 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$57.95 - $66.61 $1.31 Million - $1.5 Million	-22,569 Reduced 54.99%	18,470 $1.14 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $372,195 - $546,213	6,195 Added 17.78%	41,039 $2.47 Million
Q2 2019 Aug 09, 2019	BUY	$81.3 - $97.35 $20,325 - $24,337	250 Added 0.72%	34,844 $2.94 Million
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $2.39 Million - $3.66 Million	34,594 New	34,594 $3.3 Million

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$11.1 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.7 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.86 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.79 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account